Sorry!! The article you are trying to read is not available now.
Thank you very much;
you're only a step away from
downloading your reports.

New Stock Coverage: The Coca-Cola Company Poised for Nice Pop


Wall Street ratings agencies set the tone for today's stock market.

The Dow (^DJI) ended sharply higher in its sixth successive triple-digit move. (Although adjusted for inflation - which is apparently absent everywhere else in the economy - 100-point days clearly aren't what they were.) On the day a new poll revealed 70 million Americans are miserable at work, a broker boost sent professional networking name LinkedIn Corp (LNKD) up 1.03%.

Oil hit a nine-month high, just in time for a new "reality" show on the commodity. The big screen was similarly good to Nokia (NOK), one of countless companies currently shilling themselves for Man of Steel. It surged some 4.61%.

This afternoon the Federal Open Market Committee concludes its two-day monetary policy meeting, to be followed by Ben Bernanke's press conference. In earnings action, expect announcements from FedEx (FDX), Hennes & Mauritz (HNNMY), Jabil Circuit (JBL), Micron Technology (MU), and Red Hat (RHT).

Beverages: Credit Suisse has new Neutrals on Dr Pepper Snapple Group Inc. (DPS) and PepsiCo, Inc. (PEP) but is more bullish on Outperform-rated Dow (^DJI) component The Coca-Cola Company (KO).

Credit Cards: MasterCard Inc (MA) and Visa Inc (V) are each established with Overweights at Morgan Stanley.

Keryx Biopharmaceuticals (KERX): JPMorgan starts the stock at Overweight, sending shares surging 7% before the bell.

Neurocrine Biosciences, Inc. (NBIX): NBIX is a new Outperform with a $16 price objective at Oppenheimer, which notes elagolix aimed at treating endometriosis and uterine fibroids has potential promise.

Superior Energy Services, Inc. (SPN): Citing the company's good international growth prospects, Cowen starts coverage at Outperform. Its target price is $34.

Teva Pharmaceutical Industries Ltd (TEVA): The generic drug giant gets begun with a Buy recommendation and $56 objective at Maxim Group. Although Copaxone to treat Multiple Sclerosis is going off patent, the broker believes growth opportunities exist elsewhere for the firm.

Ubiquiti Networks Inc (UBNT): Shares are assigned an Outperform at JMP Securities.

The Western Union Company (WU): Morgan Stanley starts Equal Weight-research on the money transfer outfit.

(See also: Stock Upgrades: Adobe Systems Incorporated Is No 'Flash' in the Pan and Stock Downgrades: American Eagle Outfitters Gets Its Wings Clipped.)
< Previous
  • 1
Next >
No positions in stocks mentioned.
The information on this website solely reflects the analysis of or opinion about the performance of securities and financial markets by the writers whose articles appear on the site. The views expressed by the writers are not necessarily the views of Minyanville Media, Inc. or members of its management. Nothing contained on the website is intended to constitute a recommendation or advice addressed to an individual investor or category of investors to purchase, sell or hold any security, or to take any action with respect to the prospective movement of the securities markets or to solicit the purchase or sale of any security. Any investment decisions must be made by the reader either individually or in consultation with his or her investment professional. Minyanville writers and staff may trade or hold positions in securities that are discussed in articles appearing on the website. Writers of articles are required to disclose whether they have a position in any stock or fund discussed in an article, but are not permitted to disclose the size or direction of the position. Nothing on this website is intended to solicit business of any kind for a writer's business or fund. Minyanville management and staff as well as contributing writers will not respond to emails or other communications requesting investment advice.

Copyright 2011 Minyanville Media, Inc. All Rights Reserved.
Featured Videos